Business description: Wasatch Pharmaceutical, Inc.

Executive Committee: Wasatch Pharmaceutical, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Gary V. Heesch
CEO | Chief Executive Officer | - | 01/11/2010 |
| President | - | 01/11/2010 | |
Robert Meader
SAM | Sales & Marketing | - | 02/11/2010 |
Company details: Wasatch Pharmaceutical, Inc.
Wasatch Pharmaceutical, Inc.
310 East 4500 South
84107, Murray
+

Other Personal Products
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.20% | +0.09% | -8.82% | -5.59% | 336B | ||
| +0.75% | +4.19% | -9.03% | +3.98% | 137B | ||
| +1.54% | -0.95% | +5.98% | +23.90% | 72.61B | ||
| -0.17% | -2.09% | -23.54% | -22.05% | 49.48B | ||
| +6.02% | +18.40% | +11.74% | -33.32% | 36.88B | ||
| +0.69% | -0.73% | -11.80% | -19.31% | 36.61B | ||
| +0.31% | +2.12% | +5.94% | +27.76% | 20.24B | ||
| +2.14% | +3.20% | +7.53% | +9.10% | 19.58B | ||
| -1.03% | -0.51% | -26.82% | -11.37% | 9.98B | ||
| Average | +1.27% | +1.63% | -5.42% | -2.99% | 79.9B | |
| Weighted average by Cap. | +1.25% | +1.00% | -6.86% | -2.78% |

















